Chemed (CHE) Receivables - Net (2009 - 2026)

Chemed has reported Receivables - Net for 18 years, with the latest figure at $188.6 million in Q2 2026.

• Receivables - Net for Q2 2026 came in at $188.6 million, up 2.03% year-over-year; the trailing twelve-month figure through Jun 2026 was $188.6 million (up 2.03% YoY), and the FY2025 annual result was $182.6 million, up 6.67% from the prior year.
• Receivables - Net eased to $188.6 million in Q2 2026, from $215.5 million in the prior quarter.
• Over five years, Receivables - Net peaked at $285.9 million in Q1 2025 and troughed at $117.3 million in Q1 2022.
• A 5-year average of $174.5 million and a median of $179.4 million in 2023 frame the typical range for Receivables - Net.
• The widest annual swing landed in 2025, when Receivables - Net surged 61.21%; it then slipped 24.62% in 2026.
• A 5-year view of Receivables - Net shows it stood at $139.4 million in 2022, then surged by 30.2% to $181.5 million in 2023, then dropped by 5.7% to $171.2 million in 2024, then increased by 6.67% to $182.6 million in 2025, then advanced by 3.32% to $188.6 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $188.6 million in Q2 2026, $215.5 million in Q1 2026, and $182.6 million in Q4 2025.